Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PRLD
Stock Latest News
Company Announcements
Prelude Therapeutics Wins FDA IND Clearance for PRT12396
7d ago
8K
PRLD
Premium
The Fly
Prelude receives FDA clearance for investigational IND for PRT12396
7d ago
PRLD
Premium
Company Announcements
Prelude Therapeutics’ PRT2527 Trial Completion: What Investors Should Watch in Hematologic Oncology
15d ago
ONC
PRLD
Premium
Company Announcements
Prelude Therapeutics unveils strategic investor presentation on pipelines
1M ago
8K
PRLD
Premium
The Fly
Prelude Therapeutics files to sell 6.25M shares of common stock for holders
2M ago
PRLD
Premium
The Fly
Prelude Therapeutics presents data at 2025 ASH meeting from MPN programs
2M ago
PRLD
Premium
Company Announcements
Prelude Therapeutics’ Earnings Call Highlights Strategic Moves and Challenges
3M ago
PRLD
Premium
Company Announcements
Prelude Therapeutics Advances Pipeline and Strengthens Financials
3M ago
PRLD
Premium
Company Announcements
Prelude Therapeutics Reports Q3 2025 Financial Results
3M ago
8K
PRLD
Premium
The Fly
Prelude Therapeutics reports Q3 EPS (26c) vs. (43c) last year
3M ago
PRLD
Premium
The Fly
Prelude Therapeutics sees cash runway into 2027
3M ago
PRLD
Premium
Pre-Earnings
Is PRLD a Buy, Before Earnings?
3M ago
PRLD
Premium
Company Announcements
Prelude Therapeutics Signs Option Agreement with Incyte
3M ago
8K
PRLD
Premium
Market News
Why Is Prelude Therapeutics Stock (PRLD) Down 45% Today?
3M ago
INCY
PRLD
Premium
The Fly
Prelude Therapeutics announces exclusive option agreement with Incyte
3M ago
INCY
PRLD
Premium
The Fly
Prelude to prioritize JAK2V617F JH2 inhibitor, KAT6A selective degrader programs
3M ago
INCY
PRLD
Premium
The Fly
Prelude Therapeutics pauses development of SMARCA2 degrader program
3M ago
PRLD
Premium
The Fly
Prelude Therapeutics sees cash runway into 2027
3M ago
PRLD
Premium
The Fly
Prelude Therapeutics CMO Jane Huang departs
3M ago
PRLD
Premium
The Fly
Prelude Therapeutics announces publication of abstracts for ASH meeting
3M ago
PRLD
Premium
Company Announcements
Prelude Therapeutics Advances with PRT7732 in Targeted Cancer Therapy
4M ago
PRLD
Premium
Company Announcements
Prelude Therapeutics Appoints Katina Dorton to Board
4M ago
8K
PRLD
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
